A roundtable discussion with several of the women scientists at Horizon Discovery's Boulder office sharing personal reflections after Jennifer Doudna along with Emmanuelle Charpentier won the Nobel Prize in Chemistry this year.
52 result(s)
A summary of a recent publication in The CRISPR Journal showing that Horizon's integrated pooled CRISPRko and high throughput cell panel screening platform together offer clinically relevant information for therapeutic targets.
Here we talk about the role of the Edit-R Pooled sgRNA Indexing PCR Primers and answer the most common questions about the Indexing PCR and Sequencing Primer kit.
Demonstration of a repeatable pooled lentiviral sgRNA screen in primary human T cells
Gene editing by CRISPR has led to significant advances in immunotherapy development. Here we offer several tips for successful editing in T cells, including recommendations for cell handling, nucleofection, and analysis.
CRISPRテクノロジーによりゲノム編集細胞集団を作製後、クローン細胞株を用いるかプール細胞集団を用いるかを決定する際に考慮すべき最も重要な4つの事項をご説明しています。
Technology from Horizon Discovery has been awarded Top Innovation of the Year by The Scientist Magazine for the past seven consecutive years.
Interested in prime editing? Learn about this new technique and how Horizon's customizable long oligo synthesis can help get you started.
Achieve DNA-free guaranteed gene editing with synthetic predesigned sgRNA reagents and libraries covering the entire human genome.
利用できる多くの選択肢の中から最適なセルベーススクリーニングを選ぶことはたちまちに意思決定が複雑になることがあります。ここでは、主な選択肢である細胞パネルスクリーニングと機能ゲノミクススクリーニングを概観します。